ClinicalTrials.Veeva

Menu

Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150)

Organon logo

Organon

Status and phase

Completed
Phase 4

Conditions

Cardiovascular Disorder

Treatments

Drug: Ezetimibe
Drug: simvastatin

Study type

Interventional

Funder types

Industry

Identifiers

NCT00652717
2008_009
0653A-150

Details and patient eligibility

About

Collecting local data, safety and experience trial.

Enrollment

280 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients; Post Acute Coronary Syndrome

Exclusion criteria

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

280 participants in 2 patient groups

1
Experimental group
Description:
arm 1 - Ezetimibe 10 mg daily that was added on Statin Therapy (prescribed clinically suitable dose by the physician).
Treatment:
Drug: simvastatin
Drug: Ezetimibe
2
Active Comparator group
Description:
arm 2- simvastatin (prescribed clinically suitable dose by the physician), for mean follow up of 42 days.
Treatment:
Drug: simvastatin

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems